Vaccine Market Research Report Bundle (Vaccines 2012, Whats Next in Vaccines, Vaccine Production Markets).pdf
《Vaccine Market Research Report Bundle (Vaccines 2012, Whats Next in Vaccines, Vaccine Production Markets).pdf》由会员分享,可在线阅读,更多相关《Vaccine Market Research Report Bundle (Vaccines 2012, Whats Next in Vaccines, Vaccine Production Markets).pdf(631页珍藏版)》请在三一文库上搜索。
1、VACCINE MARKET REPORT BUNDLE REPORT BUNLDE Report RE BUNDLE May 2012 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f THIS REPORT BUNDLE INCLUDES THREE KALORAMA REPORTS: VACCINES 2012 WHATS NEXT IN VAC
2、CINES VACCINE PRODUCTION Vaccines 2012 September 2012 Kalorama Information A division of MarketR 38 East 29th Street Sixth Floor New York, New York 10016 212.807 .2660 t 800.298.5603 t 212.807 .2676 f VACCINES2012 THEWORLDMARKET AKALORAMA INFORMATION MARKETINTELLIGENCE REPORT Vaccines 2012 has been
3、 prepared by Kalorama Information. We serve business and industrial clients worldwide with a complete line of information services and research publications. Kalorama Information Market Intelligence Reports are specifically designed to aid the action-oriented executive by providing a thorough presen
4、tation of essential data and concise analysis. Author: Alison Sahoo Publication Date: September 2012 38 East 29th Street New York, New York 10016 (800) 298-5699 Outside the U.S. (212) 807-2657 FAX: (212) 807-2676 http:/www.KaloramaI E-MAIL: Copyright 2012 Kalorama Information, LLC. Reproduction wit
5、hout prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Copyright 2012 Kalorama Information, LLC. Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part
6、, is strictly prohibited. CHAPTER ONE: EXECUTIVE SUMMARY 1? The Global Vaccines Industry 1? Scope and Methodology 1? Overview . 2? Pediatric Preventative Vaccines 3? The Market 5? Adult Preventative Vaccines . 8? The Market 10? Total Market 12? Issues and Trends 14? CHAPTER TWO: INTRODUCTION TO VACC
7、INES 19? A Brief History: The Development of Vaccines . 20? The Immune Response 21? Mechanism of Action 21? Types of Vaccines 22? Attenuated (Weakened) Live Viruses . 22? Killed (Inactivated) Viruses 24? Toxoid Vaccines . 25? Genetically Engineered/Modified Vaccines . 25? Vaccine Approval Process 27
8、? CHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES .33? Introduction . 33? Childhood Immunization in the United States . 35? Childhood Immunization Rates 37? Challenges to the Vaccine Delivery System . 37? The Effect of U.S. Healthcare Reform 38? Recommended Childhood Immunization Schedule 39? State Imm
9、unization Recommendations 47? United Nations Initiatives . 47? Pediatric Vaccine Products 48? BCG 48? Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio 49? Haemophilus Influenzae Type B . 56? Hepatitis A 57? Measles, Mumps and Rubella . 58? Meningococcal Disease. 62? Pneumococcal Conjugate 64? R
10、otavirus . 66? Varicella 69? Copyright 2012 Kalorama Information, LLC. Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Copyright 2012 Kalorama Information, LLC. Reproduction without prior written pe
11、rmission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Pediatric Vaccines in Development 70? Cost of Vaccines in the United States 70? The World Market for Pediatric Preventive Vaccines . 73? Total Market Size and Forecast 73? Hepatitis Vacci
12、ne Market 79? Haemophilus Influenzae Type B Vaccine Market 81? Measles, Mumps and Rubella Vaccines . 83? Combination Vaccines Market 86? Pneumococcal Vaccine . 89? Poliovirus Vaccine 92? Varicella Vaccines 94? Other Vaccines Market . 96? CHAPTER FOUR: ADULT PREVENTIVE VACCINES 101? Introduction . 10
13、1? Adult Vaccine-Preventable Diseases: Facts and Figures . 102? Global Influenza Surveillance Program 104? U.S. Surveillance 105? Recommendations for Adult Immunizations 105? Adult Vaccine Products 109? Cervical Cancer . 112? Cholera 119? Diphtheria-Tetanus . 121? Hepatitis 122? Influenza . 125? Jap
14、anese Encephalitis 133? Pneumococcal Disease 134? Rabies 135? Shingles . 136? Typhoid Fever . 138? Yellow Fever . 138? Adult Vaccines in Development . 139? The World Market for Adult Preventive Vaccines 141? Total Market Size and Forecast 141? Cervical Cancer Market 146? Hepatitis Market 148? Influe
15、nza Vaccine Market . 151? Travel, DT, and Miscellaneous Vaccine Market 157? CHAPTER FIVE: VACCINES MARKET SUMMARY .161? Trends Driving the Vaccines Market 161? Market Size and Forecast . 164? Vaccine Sales by Region. 168? Vaccine Market Competitors 170? Copyright 2012 Kalorama Information, LLC. Repr
16、oduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Copyright 2012 Kalorama Information, LLC. Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or
17、 in any part, is strictly prohibited. Pediatric Vaccines . 173? Adult Vaccines 177? CHAPTER SIX: ISSUES AND TRENDS .179? Vaccine Safety 179? Refusal to Immunize . 179? Obesity 182? Post-Licensure Surveillance 182? The Vaccine Injury Compensation Program . 184? World Health Organization . 185? Other
18、Initiatives 186? The Future of Vaccine Safety . 187? Vaccine Shortages . 187? Preventing Shortages in the Developed Countries 188? Preventing Shortages in Developing Nations . 189? Preventing Pandemics . 191? U.S. National Vaccine Plan . 191? Vaccines and Bioterrorism . 192? Overview . 192? Project
19、Bioshield Act 192? National Bio and Agro-Defense Facility 194? Vaccine Treatment and Evaluation Units . 195? Anthrax . 196? Smallpox . 197? DNA Vaccination . 199? Innovations in Vaccine Delivery Systems 200? Mucosal Delivery 201? Intranasal Delivery 202? Vaccine Patches 204? Vaccine Chips and Micron
20、eedles 205? Innovations in Vaccine Production 205? Plants . 206? Insects . 208? Nanoparticle Systems 208? Cloning 209? CHAPTER SEVEN: COMPANY PROFILES .211? AlphaVax, Inc. . 211? History and Lines of Business 211? Strategic Alliances 212? Vaccine Products 213? Financial Information 213? Bavarian Nor
21、dic A/S . 214? History and Lines of Business 214? Strategic Alliances 214? Copyright 2012 Kalorama Information, LLC. Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Copyright 2012 Kalorama Informati
22、on, LLC. Reproduction without prior written permission, in any media now in existence or hereafter developed, in whole or in any part, is strictly prohibited. Vaccine Products 215? Financial Information 215? Baxter Healthcare . 216? History and Lines of Business 216? Strategic Alliances 216? Vaccine
23、 Products 217? Financial Information 217? Bharat Biotech . 218? History and Lines of Business 218? Strategic Alliances 218? Vaccine Products 218? Financial Information 219? Crucell /Johnson Diphtheria-Tetanus; Miscellaneous Vaccines Market 2007-2016 . 158? CHAPTER FIVE: VACCINES MARKET SUMMARY? Figu
24、re 5-1: Sales Growth of Vaccines vs. Pharmaceuticals 2007-2016 163? Figure 5-2: The World Vaccines Market by Vaccine Type 2007-2016 Revenues 165 Figure 5-3 World Market for Vaccines Share by Type, 2007, 2011 and 2016 . 167? Copyright 2012 Kalorama Information, LLC. Reproduction without prior written
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- Vaccine Market Research Report Bundle Vaccines 2012 Whats Next in Vaccines Production Markets Vaccines
链接地址:https://www.31doc.com/p-3802129.html